Total submissions: 31
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000115256 | SCV000149165 | benign | not specified | 2015-04-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000119166 | SCV000153893 | benign | Ataxia-telangiectasia syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000115256 | SCV000301684 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000115256 | SCV000602565 | likely benign | not specified | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000579980 | SCV000682434 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589845 | SCV000694360 | benign | not provided | 2017-02-09 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000119166 | SCV000792935 | likely benign | Ataxia-telangiectasia syndrome | 2017-07-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000589845 | SCV000840964 | benign | not provided | 2018-08-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000115256 | SCV000854937 | likely benign | not specified | 2018-05-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000119166 | SCV001138567 | likely benign | Ataxia-telangiectasia syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000589845 | SCV001148446 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ATM: PM2:Supporting, BP4 |
Illumina Laboratory Services, |
RCV000119166 | SCV001261063 | uncertain significance | Ataxia-telangiectasia syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
CHEO Genetics Diagnostic Laboratory, |
RCV001798326 | SCV002042939 | likely benign | Breast and/or ovarian cancer | 2023-05-23 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000115256 | SCV002071012 | benign | not specified | 2021-02-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000579980 | SCV002538193 | benign | Hereditary cancer-predisposing syndrome | 2020-08-21 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000115256 | SCV002570210 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579980 | SCV002673261 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000589845 | SCV002774005 | benign | not provided | 2022-09-22 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589578 | SCV005083954 | benign | Familial cancer of breast | 2024-06-17 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
True Health Diagnostics | RCV000579980 | SCV000886666 | likely benign | Hereditary cancer-predisposing syndrome | 2018-08-07 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357795 | SCV001553377 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | ATM, EXON52, c.7788+8G>T, r.(spl)?, Heterozygous, Likely Benign The ATM c.7788+8G>T variant was not identified in the literature nor was it identified in the Cosmic, MutDB, or LOVD 3.0 databases. The variant was identified in the following databases: dbSNP (ID: rs112775908) as “With other allele”, ClinVar (as likely benign by ARUP Laboratories and PreventionGenetics, and as benign by GeneDx and Invitae), Clinvitae (as likely benign and benign). The variant was identified in control databases in 404 of 276410 chromosomes (1 homozygous) at a frequency of 0.001462 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Observations by population include African in 7 of 24012 chromosomes (freq: 0.000292), Other in 4 of 6446 chromosomes (freq: 0.000621), Latino in 18 of 34394 chromosomes (freq: 0.000523), European (Non-Finnish) in 355 (1 homozygous) of 126082 chromosomes (freq: 0.002816), Ashkenazi Jewish in 11 of 10126 chromosomes (freq: 0.001086), and European (Finnish) in 9 of 25766 chromosomes (freq: 0.000349), while the variant was not observed in the East Asian and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Diagnostic Laboratory, |
RCV000589845 | SCV001740244 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000589845 | SCV001797407 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000589845 | SCV001809671 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000589845 | SCV001906323 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000589845 | SCV001918095 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000589845 | SCV001929071 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Institute for Biomarker Research, |
RCV000579980 | SCV001950172 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-15 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000589845 | SCV001957082 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000589845 | SCV001966043 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000119166 | SCV002083634 | likely benign | Ataxia-telangiectasia syndrome | 2019-10-30 | no assertion criteria provided | clinical testing |